Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tam L Nguyen

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Biophysical Journal|July 23, 2008
Sizing the Bacillus anthracis PA63 channel with nonelectrolyte poly(ethylene glycols)Brian J Nablo, Kelly M Halverson, Joseph W F Robertson, et al.
Bioorganic & Medicinal Chemistry|December 16, 2004
Conformational sampling of the botulinum neurotoxin serotype A light chain: implications for inhibitor bindingJames C Burnett, James J Schmidt, Connor F McGrath, et al.
Journal of Medicinal Chemistry|January 31, 2012
Substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and analogues: synthesis, cytotoxic activity, and study of the mechanism of actionAldo Andreani, Massimiliano Granaiola, Alessandra Locatelli, et al.
Chemmedchem|November 14, 2008
Three-dimensional database mining identifies a unique chemotype that unites structurally diverse botulinum neurotoxin serotype A inhibitors in a three-zone pharmacophoreAnn R Hermone, James C Burnett, Jonathan E Nuss, et al.
Journal of Virology|March 30, 2005
Association of ebola virus matrix protein VP40 with microtubulesGordon Ruthel, Gretchen L Demmin, George Kallstrom, et al.
The Journal of Chemical Physics|August 17, 2013
Anthrax toxin-induced rupture of artificial lipid bilayer membranesBrian J Nablo, Rekha G Panchal, Sina Bavari, et al.
Pharmaceutical Research|April 10, 2016
FG-3019, a Human Monoclonal Antibody Recognizing Connective Tissue Growth Factor, is Subject to Target-Mediated Drug DispositionMitchell C Brenner, Wojciech Krzyzanski, James Z Chou, et al.
Biochemical and Biophysical Research Communications|September 27, 2003
Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activityJames C Burnett, James J Schmidt, Robert G Stafford, et al.
Journal of Medicinal Chemistry|April 10, 2007
A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloproteaseJames C Burnett, Dejan Opsenica, Kamaraj Sriraghavan, et al.
The Journal of Biological Chemistry|November 10, 2006
Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neuronsJames C Burnett, Gordon Ruthel, Christian M Stegmann, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Biophysical Journal|July 23, 2008
Sizing the Bacillus anthracis PA63 channel with nonelectrolyte poly(ethylene glycols)Brian J Nablo, Kelly M Halverson, Joseph W F Robertson, et al.
Bioorganic & Medicinal Chemistry|December 16, 2004
Conformational sampling of the botulinum neurotoxin serotype A light chain: implications for inhibitor bindingJames C Burnett, James J Schmidt, Connor F McGrath, et al.
Journal of Medicinal Chemistry|January 31, 2012
Substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and analogues: synthesis, cytotoxic activity, and study of the mechanism of actionAldo Andreani, Massimiliano Granaiola, Alessandra Locatelli, et al.
Chemmedchem|November 14, 2008
Three-dimensional database mining identifies a unique chemotype that unites structurally diverse botulinum neurotoxin serotype A inhibitors in a three-zone pharmacophoreAnn R Hermone, James C Burnett, Jonathan E Nuss, et al.
Journal of Virology|March 30, 2005
Association of ebola virus matrix protein VP40 with microtubulesGordon Ruthel, Gretchen L Demmin, George Kallstrom, et al.
The Journal of Chemical Physics|August 17, 2013
Anthrax toxin-induced rupture of artificial lipid bilayer membranesBrian J Nablo, Rekha G Panchal, Sina Bavari, et al.
Pharmaceutical Research|April 10, 2016
FG-3019, a Human Monoclonal Antibody Recognizing Connective Tissue Growth Factor, is Subject to Target-Mediated Drug DispositionMitchell C Brenner, Wojciech Krzyzanski, James Z Chou, et al.
Biochemical and Biophysical Research Communications|September 27, 2003
Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activityJames C Burnett, James J Schmidt, Robert G Stafford, et al.
Journal of Medicinal Chemistry|April 10, 2007
A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloproteaseJames C Burnett, Dejan Opsenica, Kamaraj Sriraghavan, et al.
The Journal of Biological Chemistry|November 10, 2006
Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neuronsJames C Burnett, Gordon Ruthel, Christian M Stegmann, et al.
Pageof 2